Search Results - "Current opinion in virology"

Refine Results
  1. 1

    Transmission routes of respiratory viruses among humans by Kutter, Jasmin S, Spronken, Monique I, Fraaij, Pieter L, Fouchier, Ron AM, Herfst, Sander

    Published in Current opinion in virology (01-02-2018)
    “…•Respiratory viruses are transmitted via contact, droplets or aerosols.•Most studies on inter-human transmission routes are inconclusive.•The relative…”
    Get full text
    Journal Article
  2. 2

    Emerging and re-emerging coronaviruses in pigs by Wang, Qiuhong, Vlasova, Anastasia N, Kenney, Scott P, Saif, Linda J

    Published in Current opinion in virology (01-02-2019)
    “…[Display omitted] •Three coronaviruses are emerging/reemerging in pigs.•The three porcine coronaviruses may have originated from other species.•The clinical…”
    Get full text
    Journal Article
  3. 3

    Structure of SARS-CoV-2 spike protein by Zhang, Jun, Xiao, Tianshu, Cai, Yongfei, Chen, Bing

    Published in Current opinion in virology (01-10-2021)
    “…The COVID-19 (coronavirus disease 2019) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to loss of human life in…”
    Get full text
    Journal Article
  4. 4

    Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19 by Painter, George R, Natchus, Michael G, Cohen, Oren, Holman, Wendy, Painter, Wendy P

    Published in Current opinion in virology (01-10-2021)
    “…•Molnupiravir is a broad acting, oral antiviral versus SARS-CoV-2, flu, Ebola and others.•Clinical development was greatly accelerated in response to the…”
    Get full text
    Journal Article
  5. 5

    Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection by Vandyck, Koen, Deval, Jerome

    Published in Current opinion in virology (01-08-2021)
    “…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-19 pandemic. The coronavirus 3-chymotrypsin-like protease (3CLpro)…”
    Get full text
    Journal Article
  6. 6

    Nucleoside analogues for the treatment of coronavirus infections by Pruijssers, Andrea J, Denison, Mark R

    Published in Current opinion in virology (01-04-2019)
    “…•Coronaviruses (CoV) represent current and future risk for pandemic zoonotic infections.•Nucleoside analogues are highly active across multiple virus…”
    Get full text
    Journal Article
  7. 7

    In vivo tissue-tropism of adeno-associated viral vectors by Srivastava, Arun

    Published in Current opinion in virology (01-12-2016)
    “…•AAV is a non-pathogenic virus, and recombinant AAV vectors have proven to be highly efficient for gene delivery to a wide variety of cell types, tissue, and…”
    Get full text
    Journal Article
  8. 8

    Current status and prospects of HIV treatment by Cihlar, Tomas, Fordyce, Marshall

    Published in Current opinion in virology (01-06-2016)
    “…•With no available cure, treatment of HIV infection requires life-long therapy.•A combination of three drugs is the current standard for chronic HIV…”
    Get full text
    Journal Article
  9. 9

    Immune history and influenza virus susceptibility by Cobey, Sarah, Hensley, Scott E

    Published in Current opinion in virology (01-02-2017)
    “…•Early viral infections shape B cell response recalled against future viral strains.•Competition between memory and naïve B cells occurs in secondary viral…”
    Get full text
    Journal Article
  10. 10

    Interferon-stimulated genes and their antiviral effector functions by Schoggins, John W, Rice, Charles M

    Published in Current opinion in virology (01-12-2011)
    “…► IFN induces a diverse range of antiviral effectors. ► Each virus has a unique, but partially overlapping, antiviral ‘ISG profile’. ► IFN effectors target…”
    Get full text
    Journal Article
  11. 11

    Baloxavir marboxil: the new influenza drug on the market by O’Hanlon, Ryan, Shaw, Megan L

    Published in Current opinion in virology (01-04-2019)
    “…•Approval of first endonuclease inhibitor for influenza treatment.•Represents a new class of influenza drug.•Single dose is clinically effective. For the first…”
    Get full text
    Journal Article
  12. 12

    Emerging viruses in aquaculture by Kibenge, Frederick SB

    Published in Current opinion in virology (01-02-2019)
    “…[Display omitted] •There is a continuous emergence of viral diseases in aquaculture.•Emergence of viral diseases in aquaculture may be driven by virus, animal…”
    Get full text
    Journal Article
  13. 13

    Engineering virus-like particles as vaccine platforms by Frietze, Kathryn M, Peabody, David S, Chackerian, Bryce

    Published in Current opinion in virology (01-06-2016)
    “…•VLP have been engineered to improve their utility as vaccine platforms.•Targeted engineering of VLPs has enhanced immunogenicity, stability, and…”
    Get full text
    Journal Article
  14. 14

    Future considerations for the mRNA-lipid nanoparticle vaccine platform by Igyártó, Botond Z, Jacobsen, Sonya, Ndeupen, Sonia

    Published in Current opinion in virology (01-06-2021)
    “…Vaccines based on mRNA-containing lipid nanoparticles (LNPs) pioneered by Katalin Karikó and Drew Weissman at the University of Pennsylvania are a promising…”
    Get full text
    Journal Article
  15. 15

    Thrips transmission of tospoviruses by Rotenberg, Dorith, Jacobson, Alana L, Schneweis, Derek J, Whitfield, Anna E

    Published in Current opinion in virology (01-12-2015)
    “…•Research is revealing greater genetic diversity of thrips vectors and tospoviruses.•Specific thrips–tospovirus population interactions underlie transmission…”
    Get full text
    Journal Article
  16. 16

    Viral diseases of the central nervous system by Swanson, Phillip A, McGavern, Dorian B

    Published in Current opinion in virology (01-04-2015)
    “…•A diverse spectrum of viruses can enter the CNS, causing acute and chronic neurological disorders.•Virus-induced CNS diseases are influenced by routes of…”
    Get full text
    Journal Article
  17. 17

    Recent advances in antiviral drug development towards dengue virus by Troost, Berit, Smit, Jolanda M

    Published in Current opinion in virology (01-08-2020)
    “…•Evaluating drug efficacy, specificity and toxicity may help to develop an optimal treatment regime for in vivo studies.•Measuring time to resolve viremia in…”
    Get full text
    Journal Article
  18. 18

    Zoonotic disease and virome diversity in bats by Van Brussel, Kate, Holmes, Edward C

    Published in Current opinion in virology (01-02-2022)
    “…The emergence of zoonotic viral diseases in humans commonly reflects exposure to mammalian wildlife. Bats (order Chiroptera) are arguably the most important…”
    Get full text
    Journal Article
  19. 19

    Global overview and major challenges of host prediction methods for uncultivated phages by Coclet, Clément, Roux, Simon

    Published in Current opinion in virology (01-08-2021)
    “…•Global phage diversity is now primarily explored through cultivation-independent metagenomics.•Metagenome-derived phages are typically linked to their host(s)…”
    Get full text
    Journal Article
  20. 20

    Virus recognition of glycan receptors by Thompson, Andrew J, de Vries, Robert P, Paulson, James C

    Published in Current opinion in virology (01-02-2019)
    “…[Display omitted] •Most mammalian virus families use cell-surface glycans as receptors.•Glycan receptors are diverse in structure and distribution, giving rise…”
    Get full text
    Journal Article